Targeting Chemoresistant Tumors: Could TRIM Proteins-p53 Axis Be a Possible Answer?

Chemosensitivity is a crucial feature for all tumours so that they can be successfully treated, but the huge heterogeneity of these diseases, to be intended both inter- and intra-tumour, makes it a hard-to-win battle. Indeed, this genotypic and phenotypic variety, together with the adaptability of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Valletti, Alessio, Marzano, Flaviana, Pesole, Graziano, Sbisà, Elisabetta, Tullo, Apollonia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479553/
https://www.ncbi.nlm.nih.gov/pubmed/30974870
http://dx.doi.org/10.3390/ijms20071776

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479553/
https://www.ncbi.nlm.nih.gov/pubmed/30974870
http://dx.doi.org/10.3390/ijms20071776

Ejemplares similares